Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise - 06/09/18
Doi : 10.1016/j.ahj.2018.05.015
Louise Balling, MD, PhD a, ⁎ 
, Jakob Hartvig Thomsen, MD, PhD a, Emil Wolsk, MD, PhD a, Christian Hassager, MD, PhD, DMSci a, Søren Boesgaard, MD, PhD, DMSci a, Steven R. Goldsmith, MD b, Finn Gustafsson, MD, PhD, DMSci a
, Jakob Hartvig Thomsen, MD, PhD a, Emil Wolsk, MD, PhD a, Christian Hassager, MD, PhD, DMSci a, Søren Boesgaard, MD, PhD, DMSci a, Steven R. Goldsmith, MD b, Finn Gustafsson, MD, PhD, DMSci a a Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
b Hennepin County Medical Center, University of Minnesota, Minneapolis, MN
⁎Reprint requests: L. Balling, Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.Department of CardiologyUniversity Hospital of Copenhagen, RigshospitaletCopenhagenDenmark
Résumé |
Heart failure is associated with a reduced exercise capacity. Our aim was to investigate if infusion with a V1A/V2-receptor antagonist, conivaptan, leads to an increase in cardiac output at a constant or reduced filling pressure (pulmonary capillary wedge pressure) during submaximal exercise.
Le texte complet de cet article est disponible en PDF.Plan
| ☆ | RCT No. NCT01752543 |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 203
P. 101-104 - septembre 2018 Retour au numéro
Article précédent
- First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization
- Adriana Luk, John D. Groarke, Akshay S. Desai, Syed Saad Mahmood, Deepa M. Gopal, Emer Joyce, Sachin P. Shah, Joann Lindenfeld, Lynne Stevenson, Neal K. Lakdawala
- Does self-monitoring and self-management of blood pressure after stroke or transient ischemic attack improve control? TEST-BP, a randomized controlled trial
- William J. Davison, Phyo K. Myint, Allan B. Clark, Lois G. Kim, Edward C. Wilson, Maggie Langley, John F. Potter
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?